Literature DB >> 6487906

Potentiation of the action of adenosine on cerebral cortical neurones by the tricyclic antidepressants.

J W Phillis.   

Abstract

The effects of four tricyclic antidepressants, nortriptyline, iprindole, chlorimipramine and desipramine on adenosine-evoked depressions of the firings of rat cerebral cortical neurones has been studied. When applied iontophoretically, all four substances enhanced the depressant actions of iontophoretically applied adenosine but did not affect the depressant actions of the uptake-resistant analogue, adenosine 5'-N-ethylcarboxamide (NECA). Nortriptyline and iprindole administered intravenously (1 mg kg-1) enhanced the depressant actions of iontophoretically applied adenosine. When applied by larger iontophoretic currents, all four antidepressants inhibited the firing of cerebral cortical neurones. Chlorimipramine- and desimipramine-elicited depressions were antagonized by intravenously administered caffeine, an adenosine antagonist. Earlier studies showed the tricyclic antidepressants inhibit the uptake of adenosine by rat brain cerebral cortical synaptosomes. The present results demonstrate that four antidepressants are able to potentiate the action of adenosine and that this occurs when these compounds are given in behaviourally meaningful doses. The specificity of the potentiation is demonstrated by the failure of these compounds to potentiate the depressant actions of an uptake-resistant analogue of adenosine, NECA. Antagonism of the inhibitory effects of the antidepressants on neuronal firings by caffeine, indicates that these compounds can enhance the extracellular levels of endogenously released adenosine sufficiently to depress cell firing.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6487906      PMCID: PMC1987110          DOI: 10.1111/j.1476-5381.1984.tb16521.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  Adenosine as a putative transmitter in the cerebral cortex. Studies with potentiators and antagonists.

Authors:  J W Phillis; G K Kostopoulos
Journal:  Life Sci       Date:  1975-10-10       Impact factor: 5.037

2.  The release of 3H-adenosine and its derivatives from cat sensorimotor cortex.

Authors:  P V Sulakhe; J W Phillis
Journal:  Life Sci       Date:  1975-08-15       Impact factor: 5.037

3.  Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain.

Authors:  J Vetulani; F Sulser
Journal:  Nature       Date:  1975-10-09       Impact factor: 49.962

4.  Centrally-acting drugs and related compounds examined for action on output of adenine derivatives from superfused tissues of the brain.

Authors:  I Pull; H McIlwain
Journal:  Biochem Pharmacol       Date:  1976-02-01       Impact factor: 5.858

5.  Psychoactive drug effects on a system which generates cyclic AMP in brain.

Authors:  J Schultz
Journal:  Nature       Date:  1976-06-03       Impact factor: 49.962

6.  Effect of psychotropic drugs on phosphodiesterase and cyclic AMP level in rat brain in vivo.

Authors:  S Berndt; U Schwabe
Journal:  Brain Res       Date:  1973-12-07       Impact factor: 3.252

7.  Stimulated formation of adenosine 3',5'-monophosphate by desipramine in brain slices.

Authors:  T Kodama; Y Matsukado; T Suzuki; S Tanaka; H Shimizu
Journal:  Biochim Biophys Acta       Date:  1971-10

8.  Interrelationships among the levels of ATP, adenosine and cyclic AMP in incubated slices of guinea-pig cerebral cortex: effects of depolarizing agents, psychotropic drugs and metabolic inhibitors.

Authors:  M Huang; J W Daly
Journal:  J Neurochem       Date:  1974-08       Impact factor: 5.372

9.  Brain levels of imipramine and desipramine after combined treatment with these drugs in rats.

Authors:  A Jori; D Bernardi; G Muscettola; S Garattini
Journal:  Eur J Pharmacol       Date:  1971-06       Impact factor: 4.432

10.  Effects of imipramine and desipramine on responses of single cortical neurones to noradrenaline and 5-hydroxytryptamine.

Authors:  C M Bradshaw; M H Roberts; E Szabadi
Journal:  Br J Pharmacol       Date:  1974-11       Impact factor: 8.739

View more
  2 in total

Review 1.  Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.

Authors:  Robin Ortiz; Henning Ulrich; Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-11-07       Impact factor: 5.067

Review 2.  Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

Authors:  Rodrigo A Cunha; Sergi Ferré; Jean-Marie Vaugeois; Jiang-Fan Chen
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.